Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05233696
Title Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

triple-receptor negative breast cancer

Therapies

Nab-paclitaxel + Pembrolizumab

Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.